Zhenhai Lu
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 33
- Colorectal Cancer Surgical Treatments 16
- Colorectal Cancer Treatments and Studies 11
- Colorectal Cancer Screening and Detection 4
- Hepatology 14
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Co-authors
- Zhizhong Pan (46 shared papers)Jianhong Peng (33 shared papers)Xiaojun Wu (25 shared papers)Junzhong Lin (22 shared papers)Yujing Fang (11 shared papers)Desen Wan (24 shared papers)Qingjian Ou (9 shared papers)Rongxin Zhang (13 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Chinese Journal of Cancer (3 papers)Cancer Communications (3 papers)Journal of Cancer (3 papers)Aging (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Zhenhai Lu
52 papers receiving 1.2k citations
Zhenhai Lu's Hit Papers
Peers
Comparison fields: 5 of 80
- Cancer Research 248
- Hepatology 117
- Oncology 400
- Molecular Biology 360
- Immunology 102
Countries citing papers authored by Zhenhai Lu
This map shows the geographic impact of Zhenhai Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenhai Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenhai Lu more than expected).
Fields of papers citing papers by Zhenhai Lu
This network shows the impact of papers produced by Zhenhai Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenhai Lu. The network helps show where Zhenhai Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenhai Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer Hit paper breakdown → | 2023 | 294 |
| 2 | 2018 | 101 | |
| 3 | 2015 | 65 | |
| 4 | 2021 | 48 | |
| 5 | 2003 | 46 | |
| 6 | 2024 | 44 | |
| 7 | 2017 | 39 | |
| 8 | 2017 | 39 | |
| 9 | 2013 | 35 | |
| 10 | 2017 | 34 | |
| 11 | 2018 | 32 | |
| 12 | 2016 | 32 | |
| 13 | 2017 | 31 | |
| 14 | 2010 | 30 | |
| 15 | 2019 | 30 | |
| 16 | 2016 | 29 | |
| 17 | 2023 | 23 | |
| 18 | 2017 | 23 | |
| 19 | 2016 | 17 | |
| 20 | 2017 | 16 |
About Zhenhai Lu
Zhenhai Lu is a scholar working on Oncology, Hepatology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Colorectal Cancer Treatments and Studies (11 papers), Colorectal and Anal Carcinomas (7 papers), Gastric Cancer Management and Outcomes (7 papers), Genetic factors in colorectal cancer (6 papers), Colorectal Cancer Screening and Detection (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Cancer Research (248 citations), Hepatology (117 citations), Oncology (400 citations), Molecular Biology (360 citations) and Immunology (102 citations). Zhenhai Lu has collaborated with scholars based in China, United States and France. Frequent co-authors include Zhizhong Pan, Jianhong Peng, Xiaojun Wu, Junzhong Lin, Yujing Fang, Desen Wan, Qingjian Ou, Rongxin Zhang, Weihao Li and Yanbo Xu. Their work appears in journals such as Journal of Clinical Oncology, Chinese Journal of Cancer, Cancer Communications, Journal of Cancer and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.